雷尼替丁杂质A

C₁₃H₂₂N₄O₃S · HCl

350.86

MFCD00069339

329831573

NA.24

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

H₂ 组胺受体拮抗剂；抗溃疡剂。

Sales restrictions may apply.

pharmaceutical primary standard

EDQM

pharmaceutical (small molecule)

neat

2-8℃

Cl[H].CN\C(NCCSCc1ccc(CN(C)C)o1)=C\[N+]([O-])=O

1S/C13H22N4O3S.ClH/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;/h4-5,9,14-15H,6-8,10H2,1-3H3;1H/b13-9-;

GGWBHVILAJZWKJ-CHHCPSLASA-N

Unit quantity: 15mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

GHS07,GHS08

Danger

H315 - H317 - H319 - H334 - H335

P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338

Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

Respiratory system

11 - Combustible Solids

WGK 2